Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
filingDate |
2008-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e58878b088656359709b83b923793bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79725d056031b746eafc125a28761e01 |
publicationDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7973029-B2 |
titleOfInvention |
Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases |
abstract |
Provided is a method of treating the health-related quality-of-life (HRQOL) symptoms of a lung disease, comprising the administration of an inhalable aerosol of aztreonam lysine. The method is suitable for the short term and sustainable long term treatment of HRQOL symptoms. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399496-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841286-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9345663-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009028801-A1 |
priorityDate |
2007-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |